List of insiders holdings for COLLEGIUM PHARMACEUTICAL INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Rubric Capital Management LP Rosen David Efraim 10% Owner | 2025-08-15 16:12:20 | 0 3,132,743 | 3,132,743 | Form 4 |
| 2 | Skyline Venture Partners V LP Skyline Venture Management V LLC 10% Owner | 2017-12-07 19:03:10 | 2,949,916 0 | 2,949,916 | Form 4 |
| 3 | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner | 2017-02-13 15:13:01 | 1,389,863 0 | 1,389,863 | Form 13G |
| 4 | Frazier Healthcare VI L.P. FHM VI L.P. FHM VI L.L.C. FRAZIER ALAN D Naini Nader J Topper James N Every Nathan R 10% Owner | 2020-01-24 13:38:25 | 1,132,399 0 | 1,132,399 | Form 13D |
| 5 | KANEKO YASUNORI 10% Owner | 2017-12-07 19:05:08 | 0 800,540 | 800,540 | Form 4 |
| 6 | Ciaffoni Joseph President and CEO | 2024-02-14 16:13:23 | 444,867 0 | 444,867 | Form 4 |
| 7 | Brannelly Paul Executive Vice President & CFO | 2021-02-12 16:14:28 | 215,428 0 | 215,428 | Form 4 |
| 8 | Longitude Capital Partners LLC Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Capital Associates L.P. Longitude Venture Partners L.P. 10% Owner | 2019-02-12 17:12:32 | 158,043 0 | 158,043 | Form 13G |
| 9 | Fleming Alison B EVP & Chief Technical Officer | 2021-08-12 16:03:18 | 143,694 0 | 143,694 | Form 4 |
| 10 | Malamut Richard EVP and Chief Medical Officer | 2022-02-14 18:49:23 | 130,264 0 | 130,264 | Form 4 |
| 11 | Tupper Colleen EVP & Chief Financial Officer | 2025-11-07 16:23:09 | 126,667 0 | 126,667 | Form 4 |
| 12 | Kuhlmann Shirley R. EVP and General Counsel | 2025-03-06 18:48:35 | 108,137 0 | 108,137 | Form 4 |
| 13 | Dreyer Scott EVP & Chief Commercial Officer | 2025-08-20 16:57:07 | 103,613 0 | 103,613 | Form 4 |
| 14 | Freund John Gordon Director | 2025-08-12 17:18:53 | 70,658 31,754 | 102,412 | Form 4 |
| 15 | Karnani Vikram President and CEO | 2025-11-14 16:13:00 | 96,989 0 | 96,989 | Form 4 |
| 16 | SANTINI GINO Director | 2025-08-19 17:10:43 | 95,042 0 | 95,042 | Form 4 |
| 17 | Carlson Douglas R VP Corp. Devlp | 2015-05-06 16:16:52 | 89,720 0 | 89,720 | Form 3 |
| 18 | Kopecky Ernest A see remarks | 2015-05-06 16:18:04 | 80,770 0 | 80,770 | Form 3 |
| 19 | Smith Thomas B EVP and Chief Medical Officer | 2025-09-03 16:56:45 | 70,264 0 | 70,264 | Form 4 |
| 20 | Dieter David EVP & General Counsel | 2025-03-19 16:36:33 | 68,449 0 | 68,449 | Form 4 |
| 21 | Fallon John A. Director | 2025-11-14 16:10:00 | 64,634 0 | 64,634 | Form 4 |
| 22 | BOHLIN GAREN G Director | 2025-05-19 17:42:47 | 62,259 0 | 62,259 | Form 4 |
| 23 | Balice-Gordon Rita J. Director | 2025-05-19 17:42:31 | 56,279 0 | 56,279 | Form 4 |
| 24 | Melincoff Gwen A Director | 2024-05-16 19:23:27 | 52,468 0 | 52,468 | Form 4 |
| 25 | Heffernan Michael Thomas Director | 2025-02-12 16:10:53 | 50,328 0 | 50,328 | Form 4 |
| 26 | McFarlane Neil F. Director | 2024-05-16 19:23:00 | 49,365 0 | 49,365 | Form 4 |
| 27 | Hirsch David Director | 2020-05-22 16:24:39 | 29,259 0 | 29,259 | Form 4 |
| 28 | Saim Said VP, Pharmaceutical Devlp. | 2015-05-06 16:13:21 | 25,883 0 | 25,883 | Form 3 |
| 29 | Lurker Nancy Director | 2025-05-19 17:43:15 | 22,517 0 | 22,517 | Form 4 |
| 30 | Duke Barry S See remarks | 2017-03-21 16:43:20 | 20,087 0 | 20,087 | Form 4 |
| 31 | Paya Carlos V Director | 2025-05-19 17:37:56 | 19,582 0 | 19,582 | Form 4 |
| 32 | Schroeder Theodore R Director | 2020-05-22 16:22:11 | 19,102 0 | 19,102 | Form 4 |
| 33 | Heron Patrick J Director 10% Owner | 2015-09-14 16:02:28 | 15,000 0 | 15,000 | Form 4 |
| 34 | Nadav Eran Director | 2016-06-13 17:47:10 | 8,700 0 | 8,700 | Form 4 |